Eventide Asset Management - Q2 2023 holdings

$5.92 Billion is the total value of Eventide Asset Management's 139 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 29.5% .

 Value Shares↓ Weighting
ZNTL BuyZENTALIS PHARMACEUTICALS INC$194,022,823
+249.6%
6,877,803
+113.1%
3.28%
+222.1%
PANW SellPALO ALTO NETWORKS INC$181,570,772
+5.8%
710,621
-17.3%
3.07%
-2.5%
EXAS BuyEXACT SCIENCES CORP$175,378,344
+38.5%
1,867,714
+0.0%
2.96%
+27.6%
ODFL BuyOLD DOMINION FREIGHT LINE IN$164,488,464
+8.6%
444,864
+0.1%
2.78%
+0.0%
MTD SellMETTLER TOLEDO INTERNATIONAL$157,259,078
-22.0%
119,895
-9.1%
2.66%
-28.2%
TT BuyTRANE TECHNOLOGIES PLC$150,953,103
+4.0%
789,256
+0.1%
2.55%
-4.2%
GH BuyGUARDANT HEALTH INC$143,507,952
+226.5%
4,008,602
+113.8%
2.42%
+200.9%
DOCS SellDOXIMITY INCcl a$132,461,395
-22.0%
3,893,633
-25.8%
2.24%
-28.1%
ARGX BuyARGENX SEsponsored adr$128,250,789
+4.7%
329,076
+0.0%
2.17%
-3.6%
FLYW BuyFLYWIRE CORPORATION$126,293,255
+6.9%
4,068,726
+1.1%
2.13%
-1.6%
IDXX SellIDEXX LABS INC$120,844,071
-6.3%
240,615
-6.7%
2.04%
-13.7%
WCN BuyWASTE CONNECTIONS INC$115,690,401
+2.8%
809,420
+0.0%
1.96%
-5.3%
ROP SellROPER TECHNOLOGIES INC$113,864,018
-15.8%
236,822
-22.8%
1.92%
-22.4%
POOL BuyPOOL CORP$105,581,794
+15.0%
281,822
+5.1%
1.78%
+5.9%
LOW BuyLOWES COS INC$101,222,613
+13.0%
448,483
+0.1%
1.71%
+4.1%
GLBE SellGLOBAL E ONLINE LTD$100,849,099
+12.0%
2,463,339
-11.8%
1.70%
+3.2%
HUBS BuyHUBSPOT INC$94,929,645
+24.1%
178,409
+0.0%
1.60%
+14.3%
MIRM BuyMIRUM PHARMACEUTICALS INC$89,489,530
+80.9%
3,459,201
+68.0%
1.51%
+66.7%
DHI BuyD R HORTON INC$83,754,968
+24.6%
688,265
+0.0%
1.42%
+14.8%
APTV BuyAPTIV PLC$82,523,727
+2.2%
808,343
+12.3%
1.40%
-5.9%
NEP SellNEXTERA ENERGY PARTNERS LP$80,755,372
-8.4%
1,377,138
-5.1%
1.36%
-15.6%
EVH BuyEVOLENT HEALTH INCcl a$79,935,762
+29.5%
2,638,144
+38.6%
1.35%
+19.2%
TTD BuyTHE TRADE DESK INC$77,732,586
+27.1%
1,006,638
+0.2%
1.31%
+17.1%
LRCX BuyLAM RESEARCH CORP$75,451,192
+21.7%
117,368
+0.3%
1.28%
+12.0%
LAD BuyLITHIA MTRS INC$74,287,991
+158.6%
244,280
+94.6%
1.26%
+138.3%
KDNY BuyCHINOOK THERAPEUTICS INC$74,035,340
+122.2%
1,927,000
+33.9%
1.25%
+104.7%
KRTX BuyKARUNA THERAPEUTICS INC$73,722,061
+19.4%
339,968
+0.0%
1.25%
+10.0%
DV BuyDOUBLEVERIFY HLDGS INC$73,357,856
+30.2%
1,884,837
+0.9%
1.24%
+20.0%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$73,043,445
+7.3%
497,334
+0.3%
1.23%
-1.2%
HZNP SellHORIZON THERAPEUTICS PUB L$70,936,467
-18.8%
689,708
-13.8%
1.20%
-25.2%
DLO BuyDLOCAL LTD$69,563,703
-3.8%
5,699,607
+27.9%
1.18%
-11.3%
SWAV BuySHOCKWAVE MED INC$69,199,652
+31.9%
242,457
+0.2%
1.17%
+21.6%
XMTR BuyXOMETRY INC$67,578,814
+55.5%
3,190,690
+9.9%
1.14%
+43.3%
SHLS BuySHOALS TECHNOLOGIES GROUP INcl a$62,787,169
+26.7%
2,456,462
+12.9%
1.06%
+16.7%
TREX BuyTREX CO INC$57,856,634
+34.7%
882,499
+0.0%
0.98%
+24.1%
FIVN SellFIVE9 INC$57,171,490
-25.8%
693,408
-34.9%
0.97%
-31.6%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$56,545,713
-10.4%
2,631,257
+0.0%
0.96%
-17.4%
ENTG SellENTEGRIS INC$56,260,654
+13.8%
507,676
-15.8%
0.95%
+4.9%
MPWR BuyMONOLITHIC PWR SYS INC$52,591,931
+8.0%
97,351
+0.0%
0.89%
-0.6%
ASND SellASCENDIS PHARMA A/Ssponsored adr$51,357,395
-38.8%
575,432
-26.5%
0.87%
-43.6%
ASML BuyASML HOLDING N V$50,216,478
+6.6%
69,288
+0.1%
0.85%
-1.8%
DDOG BuyDATADOG INC$48,783,986
+35.6%
495,873
+0.1%
0.82%
+24.8%
CLDX  CELLDEX THERAPEUTICS INC NEW$46,746,718
-5.7%
1,377,7400.0%0.79%
-13.1%
SPT BuySPROUT SOCIAL INC$46,287,125
-13.1%
1,002,754
+14.6%
0.78%
-20.0%
LNG BuyCHENIERE ENERGY INC$45,889,765
-3.3%
301,193
+0.0%
0.78%
-10.9%
COUR SellCOURSERA INC$44,295,277
+13.0%
3,402,095
-0.0%
0.75%
+4.2%
NVT  NVENT ELECTRIC PLC$41,465,330
+20.3%
802,5030.0%0.70%
+10.9%
LSCC SellLATTICE SEMICONDUCTOR CORP$41,112,292
-16.1%
427,941
-16.6%
0.70%
-22.7%
COGT BuyCOGENT BIOSCIENCES INC$40,739,025
+45.8%
3,440,796
+32.9%
0.69%
+34.3%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$36,449,640
-6.4%
1,236,0000.0%0.62%
-13.8%
BuyAURA BIOSCIENCES INC$36,253,660
+54.7%
2,935,519
+16.2%
0.61%
+42.6%
NewTOAST INCcl a$36,199,2561,603,866
+100.0%
0.61%
APLS SellAPELLIS PHARMACEUTICALS INC$36,179,545
+10.8%
397,141
-19.8%
0.61%
+2.0%
INSP  INSPIRE MED SYS INC$35,132,541
+38.7%
108,2200.0%0.59%
+27.7%
HASI SellHANNON ARMSTRONG SUST INFR C$34,470,000
-15.1%
1,378,800
-2.9%
0.58%
-21.7%
 MARINUS PHARMACEUTICALS INC$34,460,919
+57.4%
3,173,1970.0%0.58%
+44.8%
SNPS SellSYNOPSYS INC$34,053,852
+10.6%
78,211
-1.9%
0.58%
+1.9%
RPRX SellROYALTY PHARMA PLC$31,960,931
-15.4%
1,039,718
-0.9%
0.54%
-22.2%
CDW  CDW CORP$31,157,382
-5.8%
169,7950.0%0.53%
-13.2%
PRTA BuyPROTHENA CORP PLC$30,395,183
+42.9%
445,155
+1.5%
0.51%
+31.8%
WDAY BuyWORKDAY INCcl a$30,204,430
+6620.6%
133,713
+6044.9%
0.51%
+6275.0%
NARI  INARI MED INC$29,820,820
-5.8%
512,9140.0%0.50%
-13.3%
TRGP BuyTARGA RES CORP$29,813,621
+30.6%
391,769
+25.2%
0.50%
+20.3%
KLAC BuyKLA CORP$29,442,654
+44.2%
60,704
+18.7%
0.50%
+32.8%
WMB BuyWILLIAMS COS INC$29,311,757
+39.3%
898,307
+27.5%
0.50%
+28.2%
ORLY BuyOREILLY AUTOMOTIVE INC$29,081,243
+12.6%
30,442
+0.1%
0.49%
+3.6%
BPMC  BLUEPRINT MEDICINES CORP$27,713,200
+40.5%
438,5000.0%0.47%
+29.3%
PRVA  PRIVIA HEALTH GROUP INC$26,110,000
-5.4%
1,000,0000.0%0.44%
-13.0%
ISRG BuyINTUITIVE SURGICAL INC$25,665,333
+33.9%
75,058
+0.0%
0.43%
+23.3%
SGEN SellSEAGEN INC$25,206,679
-55.5%
130,971
-53.2%
0.43%
-59.0%
STE SellSTERIS PLC$25,118,117
-3.8%
111,646
-18.2%
0.42%
-11.3%
IRTC  IRHYTHM TECHNOLOGIES INC$24,946,563
-15.9%
239,1350.0%0.42%
-22.4%
IMGN NewIMMUNOGEN INC$24,531,0001,300,000
+100.0%
0.42%
BEPC BuyBROOKFIELD RENEWABLE CORPcl a sub vtg$24,454,824
-9.8%
775,851
+0.1%
0.41%
-16.9%
SHW BuySHERWIN WILLIAMS CO$24,455,720
+68.1%
92,105
+42.3%
0.41%
+54.7%
BuyAMYLYX PHARMACEUTICALS INC$24,090,174
+79.3%
1,116,837
+143.8%
0.41%
+64.8%
PLD SellPROLOGIS INC.$23,594,993
-13.3%
192,408
-11.8%
0.40%
-20.2%
KROS BuyKEROS THERAPEUTICS INC$23,304,400
+81.9%
580,000
+93.3%
0.39%
+67.7%
NOVT BuyNOVANTA INC$23,199,730
+15.8%
126,017
+0.1%
0.39%
+6.5%
CWEN SellCLEARWAY ENERGY INCcl c$22,030,784
-45.8%
771,386
-40.5%
0.37%
-50.1%
MRTX BuyMIRATI THERAPEUTICS INC$21,678,000
+57.1%
600,000
+61.7%
0.37%
+44.7%
AJG SellGALLAGHER ARTHUR J & CO$21,429,812
-6.5%
97,599
-18.5%
0.36%
-13.8%
PNR BuyPENTAIR PLC$21,331,372
+42.2%
330,207
+21.6%
0.36%
+31.3%
NTLA  INTELLIA THERAPEUTICS INC$20,113,593
+9.4%
493,2220.0%0.34%
+0.9%
NewHASHICORP INC$19,612,014749,122
+100.0%
0.33%
INSM  INSMED INC$19,245,373
+23.8%
912,1030.0%0.32%
+14.0%
CMS BuyCMS ENERGY CORP$18,877,197
+173.3%
321,314
+185.5%
0.32%
+151.2%
VCYT  VERACYTE INC$18,644,040
+14.2%
732,0000.0%0.32%
+5.4%
CYTK  CYTOKINETICS INC$18,136,720
-7.3%
556,0000.0%0.31%
-14.5%
RCKT  ROCKET PHARMACEUTICALS INC$17,843,260
+16.0%
898,0000.0%0.30%
+7.1%
AKRO  AKERO THERAPEUTICS INC$17,701,113
+22.0%
379,1200.0%0.30%
+12.4%
ALKS NewALKERMES PLC$17,597,893562,233
+100.0%
0.30%
 ROIVANT SCIENCES LTD$17,038,224
+36.6%
1,690,3000.0%0.29%
+25.8%
RGEN  REPLIGEN CORP$16,833,740
-16.0%
119,0000.0%0.28%
-22.6%
RARE  ULTRAGENYX PHARMACEUTICAL IN$16,560,670
+15.0%
359,0000.0%0.28%
+6.1%
ELS  EQUITY LIFESTYLE PPTYS INC$16,504,238
-0.4%
246,7370.0%0.28%
-8.2%
BRKR  BRUKER CORP$16,321,758
-6.2%
220,8030.0%0.28%
-13.5%
BBIO  BRIDGEBIO PHARMA INC$16,188,227
+3.7%
941,1760.0%0.27%
-4.2%
XENE SellXENON PHARMACEUTICALS INC$15,935,381
-30.6%
413,906
-35.4%
0.27%
-36.1%
CERE BuyCEREVEL THERAPEUTICS HLDNG I$15,577,100
+104.7%
490,000
+57.1%
0.26%
+87.9%
FANG NewDIAMONDBACK ENERGY INC$14,942,594113,753
+100.0%
0.25%
BEAM  BEAM THERAPEUTICS INC$14,662,352
+4.3%
459,2030.0%0.25%
-3.9%
BMRN  BIOMARIN PHARMACEUTICAL INC$14,241,437
-10.9%
164,2990.0%0.24%
-17.7%
MSCI NewMSCI INC$14,273,45530,415
+100.0%
0.24%
SYY  SYSCO CORP$14,196,909
-3.9%
191,3330.0%0.24%
-11.4%
SRPT SellSAREPTA THERAPEUTICS INC$14,045,076
-45.6%
122,643
-34.5%
0.24%
-50.0%
BuyGXO LOGISTICS INCORPORATED$13,830,577
+24.5%
220,162
+0.0%
0.23%
+14.7%
BCRX BuyBIOCRYST PHARMACEUTICALS INC$13,868,800
+50.8%
1,970,000
+78.6%
0.23%
+38.5%
VRSK SellVERISK ANALYTICS INC$13,805,008
-64.2%
61,076
-69.6%
0.23%
-67.1%
BuyR1 RCM INC$13,573,757
+51.9%
735,705
+23.5%
0.23%
+39.6%
DVAX NewDYNAVAX TECHNOLOGIES CORP$13,257,0311,026,086
+100.0%
0.22%
IEX  IDEX CORP$13,164,010
-6.8%
61,1540.0%0.22%
-14.3%
EHC  ENCOMPASS HEALTH CORP$12,863,478
+25.2%
189,9790.0%0.22%
+14.8%
NBIX  NEUROCRINE BIOSCIENCES INC$12,730,500
-6.8%
135,0000.0%0.22%
-14.3%
ETNB  89BIO INC$12,167,283
+24.4%
642,0730.0%0.21%
+15.1%
VKTX NewVIKING THERAPEUTICS INC$12,157,500750,000
+100.0%
0.20%
ESI SellELEMENT SOLUTIONS INC$11,493,274
-14.2%
598,608
-13.7%
0.19%
-21.1%
RPHM NewRENEO PHARMACEUTICALS INC$11,480,0001,750,000
+100.0%
0.19%
MASS Sell908 DEVICES INC$9,816,626
-48.8%
1,430,995
-35.8%
0.17%
-52.8%
RVMD NewREVOLUTION MEDICINES INC$9,646,986360,635
+100.0%
0.16%
DNLI  DENALI THERAPEUTICS INC$9,248,641
+28.1%
313,4070.0%0.16%
+18.2%
NDAQ SellNASDAQ INC$9,107,994
-57.1%
182,708
-53.0%
0.15%
-60.5%
PTGX NewPROTAGONIST THERAPEUTICS INC$8,838,400320,000
+100.0%
0.15%
CRNX  CRINETICS PHARMACEUTICALS IN$7,834,519
+12.2%
434,7680.0%0.13%
+3.1%
EQIX NewEQUINIX INC$7,466,2459,524
+100.0%
0.13%
EGP  EASTGROUP PPTYS INC$5,773,068
+5.0%
33,2550.0%0.10%
-3.0%
TMDX NewTRANSMEDICS GROUP INC$5,665,37467,461
+100.0%
0.10%
RCUS  ARCUS BIOSCIENCES INC$4,874,400
+11.3%
240,0000.0%0.08%
+2.5%
IONS  IONIS PHARMACEUTICALS INC$4,513,300
+14.8%
110,0000.0%0.08%
+5.6%
SellARTERIS INC$2,719,639
+23.0%
398,774
-23.7%
0.05%
+12.2%
NewXOMETRY INCnote 1.000% 2/0$1,588,6502,100,000
+100.0%
0.03%
NewNERDWALLET INC$1,411,500150,000
+100.0%
0.02%
NOW BuySERVICENOW INC$509,145
+52.6%
906
+26.2%
0.01%
+50.0%
NVDA BuyNVIDIA CORPORATION$519,892
+415.6%
1,229
+238.6%
0.01%
+350.0%
COMP NewCOMPASS INCcl a$451,076128,879
+100.0%
0.01%
EW BuyEDWARDS LIFESCIENCES CORP$481,838
+44.5%
5,108
+26.7%
0.01%
+33.3%
ALGN NewALIGN TECHNOLOGY INC$416,5881,178
+100.0%
0.01%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$367,349
+94.8%
3,640
+79.6%
0.01%
+100.0%
NEE SellNEXTERA ENERGY INC$234,695
-15.3%
3,163
-12.0%
0.00%
-20.0%
MDB ExitMONGODB INCcl a$0-81
-100.0%
0.00%
DLO ExitDLOCAL LTDcall$0-3,900
-100.0%
0.00%
XPO ExitXPO INC$0-208
-100.0%
0.00%
ZI ExitZOOMINFO TECHNOLOGIES INC$0-1,067
-100.0%
0.00%
GNRC ExitGENERAC HLDGS INC$0-103
-100.0%
0.00%
ZTS ExitZOETIS INCcl a$0-2,015
-100.0%
-0.01%
PTCT ExitPTC THERAPEUTICS INC$0-34,047
-100.0%
-0.03%
FRLN ExitFREELINE THERAPEUTICS HLDGSsponsored ads$0-4,702,641
-100.0%
-0.04%
ExitRXO INC$0-115,000
-100.0%
-0.04%
TALS ExitTALARIS THERAPEUTICS INC$0-1,561,092
-100.0%
-0.05%
ALXO ExitALX ONCOLOGY HLDGS INC$0-664,829
-100.0%
-0.06%
ADCT ExitADC THERAPEUTICS SA$0-1,675,959
-100.0%
-0.06%
ExitNEXTERA ENERGY INCunit 09/01/2025$0-75,000
-100.0%
-0.06%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-501,033
-100.0%
-0.12%
ANNX ExitANNEXON INC$0-1,867,250
-100.0%
-0.13%
WEC ExitWEC ENERGY GROUP INC$0-94,165
-100.0%
-0.16%
APTVPRA ExitAPTIV PLC5.5% cnv pfd a$0-78,500
-100.0%
-0.18%
ZIP ExitZIPRECRUITER INCcl a$0-817,475
-100.0%
-0.24%
AESC ExitAES CORPunit 02/15/2024$0-156,400
-100.0%
-0.26%
BLU ExitBELLUS HEALTH INC NEW$0-2,210,000
-100.0%
-0.29%
FGEN ExitFIBROGEN INC$0-960,000
-100.0%
-0.33%
BILL ExitBILL HOLDINGS INC$0-264,398
-100.0%
-0.39%
IMVT ExitIMMUNOVANT INC$0-1,390,000
-100.0%
-0.40%
CCI ExitCROWN CASTLE INC$0-235,052
-100.0%
-0.58%
VECT ExitVECTIVBIO HLDG AG$0-3,675,644
-100.0%
-0.58%
ENPH ExitENPHASE ENERGY INC$0-171,081
-100.0%
-0.66%
RXDX ExitPROMETHEUS BIOSCIENCES INC$0-670,020
-100.0%
-1.32%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings